China SXT to acquire a 70% stake in Jiangsu Renji Pharmaceutical.

China SXT Pharmaceuticals, an innovative pharmaceutical company, agreed to acquire a 70% stake in Jiangsu Renji Pharmaceutical Chain, a pharmaceuticals company. Financial terms were not disclosed. "Renji Chain is a pharmaceutical retail chain with national online drug sales license and also the biggest retail chain integrating pharmaceutical marketing and service in Taizhou. Its market share has ranked first in the pharmaceutical retail industry in Taizhou for five consecutive years," Feng Zhou, China SXT Chief Executive Officer and Director.